tiprankstipranks
Kymera Therapeutics, Inc. (KYMR)
:KYMR
US Market

Kymera Therapeutics (KYMR) Ownership - Who Owns Kymera Therapeutics?

Compare
222 Followers

Kymera Therapeutics (KYMR) Ownership Overview

28.27%30.51%0.06%13.12%28.02%
28.27% Insiders
0.06% Other Institutional Investors
13.12% ETFs
28.02% Public Companies and
Individual Investors
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 43.70% of the company’s stock is owned by Institutional Investors, 28.27% is owned by Insiders, and 28.02% is owned by Public Companies and Individual Investors.
The ownership structure of Kymera Therapeutics (KYMR) stock is a mix of institutional, retail, and individual investors. Approximately 30.58% of the company’s stock is owned by Institutional Investors, 28.27% is owned by Insiders, and 13.12% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 03, 2025
xxxxxxxxxxxxx
$68225
Mar 03, 2025
xxxxxxxxxxxxx
$174747
Mar 03, 2025
xxxxxxxxxxxxx
$214172
Mar 03, 2025
xxxxxxxxxxxxx
$42104

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$4842605
Dec 31, 2024
xxxxxxxxxxxxx
$13129020
Dec 31, 2024
xxxxxxxxxxxxx
$21620728
Dec 31, 2024
xxxxxxxxxxxxx
$23856390

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,995,929Institution9.23%206,799,591
5,995,929Insider9.23%206,799,591
5,054,898Insider7.78%174,343,432
4,620,428Institution7.11%159,358,562
4,185,317Institution6.44%144,351,583
3,093,981Institution4.76%106,711,405
2,547,968Institution3.92%87,879,416
2,244,444Institution3.46%77,410,874
2,116,943Institution3.26%73,013,364
1,390,372Institution2.14%47,953,930

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,185,317Institution6.44%144,351,583
3,093,981Institution4.76%106,711,405
2,547,968Institution3.92%87,879,416
2,116,943Institution3.26%73,013,364
1,369,813Institution2.11%47,244,850
967,593Institution1.49%33,372,283
605,059Institution0.93%20,868,485
491,466Institution0.76%16,950,662
455,765Institution0.70%15,719,335
455,728Institution0.70%15,718,059

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,536,767Institution2.37%48,177,645
1,268,087Institution1.95%43,584,150
1,236,991Institution1.90%49,764,148
721,056Institution1.11%22,605,106
701,597Institution1.08%27,776,225
594,272Institution0.92%19,878,398
413,437Institution0.64%14,209,830
334,818Institution0.52%11,507,695
218,383Institution0.34%7,304,911
214,628Institution0.33%6,728,588

FAQ

Who Owns Kymera Therapeutics, Inc. (KYMR)?
According to the latest TipRanks data, approximately 0.06% of the company's stock is held by institutional investors, 28.27% is held by insiders, and 28.02% is held by retail investors.
    What percentage of Kymera Therapeutics, Inc. (KYMR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.06% of Kymera Therapeutics, Inc. (KYMR) stock is held by institutional investors.
      What percentage of Kymera Therapeutics, Inc. (KYMR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 28.02% of Kymera Therapeutics, Inc. (KYMR) stock is held by retail investors.
        Who owns the most shares of Kymera Therapeutics, Inc. (KYMR)?
        Felix Baker owns the most shares of Kymera Therapeutics, Inc. (KYMR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis